We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > I-Mab

News List

I-Mab gets USFDA IND approval for its proprietary TJC4 biospectrumasia
January 30, 2019
I-Mab Biopharma (I-Mab) announced recently that its IND application for TJC4, has been approved by the US Food & Drug Administration (FDA).
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs pharmafocusasia
December 03, 2018
TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer......
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine prnasia
December 26, 2017
Genexine to receive an upfront payment and entitled to tiered, single-digit royalties on net sales of HyLeukin plus milestone payments from I-Mab Biopharma (I-Mab).
I-Mab signs $120 M deal with MorphoSys biospectrumasia
December 06, 2017
MorphoSys will be receiving $120 million in upfront and milestone payments.

Previous page 1 2 3 4 5 6 Next page